CFS Investment Advisory Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
WG
FWIA
CFS Investment Advisory Services's PFE Position: Q2 2026 in Review
CFS Investment Advisory Services reduced its Pfizer (PFE) stake by 23% in Q2 2026, selling an estimated $125K and leaving 16,411 shares worth $399K. The position accounts for 0.03% of the portfolio, ranked #280.
CFS Investment Advisory Services first reported a position in PFE in Q4 2020 and has held it in 15 quarters since. The position peaked at $2.04M in Q2 2023. 799 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- CFS Investment Advisory Services held 16,411 shares of Pfizer worth $399K as of Q2 2026.
- CFS Investment Advisory Services sold 4,787 Pfizer shares in Q2 2026, an estimated $125K.
- Pfizer made up 0.03% of CFS Investment Advisory Services's portfolio in Q2 2026, its #280 holding.
- CFS Investment Advisory Services first reported a position in Pfizer in Q4 2020 and has held it in 15 quarters since.
- CFS Investment Advisory Services's Pfizer position peaked at $2.04M in Q2 2023.
- 799 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on CFS Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.